<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04538261</url>
  </required_header>
  <id_info>
    <org_study_id>1379199</org_study_id>
    <nct_id>NCT04538261</nct_id>
  </id_info>
  <brief_title>Elevation of the Fetal Buttocks Prior to External Cephalic Version</brief_title>
  <official_title>Elevation of the Fetal Buttocks Prior to External Cephalic Version</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AdventHealth</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AdventHealth</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, randomized double-blind clinical trial evaluating the effect of a&#xD;
      balloon device (Fetal Pillow) to elevate the fetal buttocks during external cephalic version&#xD;
      procedures. Eligible study population: nulliparous pregnant women between 37-40 weeks&#xD;
      estimated gestational age with a breech presenting fetus and no contraindications to external&#xD;
      cephalic version.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients meeting inclusion criteria will be offered participation in this study. After&#xD;
      performing an obstetric sonogram to determine fetal position, amniotic fluid status, fetal&#xD;
      weight and placental location, the patient will be randomized to either placement of the&#xD;
      Fetal Pillow balloon device with sham inflation (control arm) or placement of the device with&#xD;
      inflation (study arm).&#xD;
&#xD;
      The researcher will show the patient the device, open the sterile container, and insert the&#xD;
      device into the vagina per manufacturer's guidelines for all patients in the study. All&#xD;
      patients will mark a line on a 100mm VAS to assess pre-insertion and post-insertion pain. The&#xD;
      study physician will then obtain the assistance of a certified nurse midwife to inflate the&#xD;
      device or perform a sham inflation. In order for the physician investigator to remain&#xD;
      blinded, the physician will leave the room during the time of the inflation/sham inflation. A&#xD;
      certified nurse midwife previously trained to inflate the device will perform the inflation&#xD;
      or sham inflation per randomization. The assisting midwife will inflate the device with 180&#xD;
      mL of saline for those patients randomized to inflation. This will occur under a sheet so&#xD;
      that the patient is blinded to the randomization scheme. If the patient is randomized to no&#xD;
      inflation, the midwife will perform a sham inflation, also under a sheet. All patients will&#xD;
      mark a line on a 100mm VAS to assess post-inflation/sham inflation pain. The assisting&#xD;
      midwife then leaves the room, and the study physician reenters the room and proceeds with the&#xD;
      external cephalic version (ECV) procedure.&#xD;
&#xD;
      Regardless of randomization, at this point the ECV procedure proceeds using normal routine.&#xD;
      The ECV will be attempted up to four times and VAS will be assessed after each attempt. Once&#xD;
      completed, all patients will also mark a line on a 100mm VAS to assess post-ECV pain.&#xD;
&#xD;
      The research physician will then remove the Fetal Pillow. Regardless of randomization, the&#xD;
      procedure is completed per the usual routine of fetal monitoring, assessing for rupture of&#xD;
      membranes, labor or bleeding, discussing post-procedure care, then discharge home (or, less&#xD;
      likely, admitting for either observation or delivery).&#xD;
&#xD;
      The researcher will fill out the ECV portion of the data collection form. Data are collected&#xD;
      later for delivery outcomes and costs for the mother and neonate.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2020</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">August 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized trial using control and interventional arms.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
    <masking_description>Investigators and participants will not know whether participants have undergone inflation of the balloon device.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Successful external cephalic version</measure>
    <time_frame>Immediately upon completion of the ECV procedure</time_frame>
    <description>Successful conversion of breech fetus to cephalic presentation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cesarean delivery</measure>
    <time_frame>Immediately after ECV procedure or during subsequent labor and delivery</time_frame>
    <description>Presence of cesarean delivery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fetal presentation at time of delivery</measure>
    <time_frame>Labor and Delivery (approximately 12 hours)</time_frame>
    <description>Presentation of the fetus during participant delivery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost of ECV procedure and hospital stay (mother)</measure>
    <time_frame>ECV procedure and during labor, delivery, and immediate postpartum period (up to 42 days)</time_frame>
    <description>Total cost of hospital stay for mother</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost of ECV procedure and hospital stay (neonate)</measure>
    <time_frame>Birth to hospital discharge (up to 42 days)</time_frame>
    <description>Cost of neonate's hospitalization after delivery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Shoulder dystocia</measure>
    <time_frame>Labor and Delivery (approximately 12 hours)</time_frame>
    <description>Presence of shoulder dystocia during delivery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rupture of membranes</measure>
    <time_frame>Within 1 hour of ECV procedure</time_frame>
    <description>Presence of rupture of membranes after ECV procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Emergency cesarean delivery</measure>
    <time_frame>During or within 1 hour of performing ECV procedure</time_frame>
    <description>Need for emergency cesarean delivery during or after ECV procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pelvic hematoma</measure>
    <time_frame>During or within 1 hour of performing ECV procedure</time_frame>
    <description>Development of a pelvic hematoma within 1 hour of ECV procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedural pain</measure>
    <time_frame>Immediately before, during, and within 2 minutes after completing the ECV procedure</time_frame>
    <description>Visual analogue pain score prior to during and after ECV procedure (100mm visual analogue scale where 0 =no pain and 10=extreme pain).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of attempts</measure>
    <time_frame>During and immediately after ECV procedure</time_frame>
    <description>Number of attempted ECV procedures to convert fetus from breech to cephalic presentation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost of hospital stay for ECV procedure</measure>
    <time_frame>Patient arrival to labor unit for ECV procedure and discharge home (up to 72 hours)</time_frame>
    <description>Total cost of the hospital stay for the ECV procedure</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">92</enrollment>
  <condition>Breech Presentation</condition>
  <condition>External Cephalic Version</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Non-inflation of the balloon device</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Inflation of the balloon device</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Fetal Pillow insertion</intervention_name>
    <description>Inflation of balloon device used to elevate fetal buttocks prior to performing external cephalic version procedure</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Women delivering at AdventHealth Orlando campus.&#xD;
&#xD;
          2. Breech presenting part as diagnosed by bedside sonography.&#xD;
&#xD;
          3. No prior deliveries &gt;/= 20 weeks gestational age.&#xD;
&#xD;
          4. Pregnancy is between 37-40 weeks gestational age.&#xD;
&#xD;
          5. Live fetus.&#xD;
&#xD;
          6. Patient is &gt;/= age 18.&#xD;
&#xD;
          7. Patient speaks English or Spanish as primary language.&#xD;
&#xD;
          8. Patient able to understand verbal and written consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Non-breech presentation (cephalic, transverse, oblique).&#xD;
&#xD;
          2. More than 1 fetus.&#xD;
&#xD;
          3. Cervical dilation of &gt;/= 1cm.&#xD;
&#xD;
          4. Prior uterine incision.&#xD;
&#xD;
          5. Congenital uterine anomaly.&#xD;
&#xD;
          6. Body mass index more than 40 kg/m2.&#xD;
&#xD;
          7. Uterine fibroids causing soft tissue dystocia.&#xD;
&#xD;
          8. Extended fetal neck.&#xD;
&#xD;
          9. Oligohydramnios (4-quadrant amniotic fluid index &lt;/= 5cm).&#xD;
&#xD;
         10. Spontaneous rupture of membranes.&#xD;
&#xD;
         11. Any contraindication to vaginal delivery.&#xD;
&#xD;
         12. Intrauterine growth restriction (estimated fetal weight &lt;/= 10%ile).&#xD;
&#xD;
         13. Estimated fetal weight &gt; /= 5,000 grams for non-diabetic patient or &gt;/= 4,500 grams&#xD;
             for patient with pre-existing or gestational diabetes, confirmed by ultrasound.&#xD;
&#xD;
         14. Fetal gastroschisis.&#xD;
&#xD;
         15. Fetal neural tube defect.&#xD;
&#xD;
         16. Severe-range preeclampsia.&#xD;
&#xD;
         17. Patient had regional anesthesia immediately prior to ECV.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David A Hill, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>AdventHealth</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ariana Mora</last_name>
    <role>Study Director</role>
    <affiliation>AdventHealth</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>David A Hill, MD</last_name>
    <phone>407-303-1444</phone>
    <email>D.Hill.MD@AdventHealth.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ariana Mora</last_name>
    <phone>407-303-9415</phone>
    <email>Ariana.Mora@AdventHealth.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>AdventHealth Orlando</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32804</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ariana Mora</last_name>
      <phone>407-303-9415</phone>
      <email>Ariana.Mora@AdventHealth.com</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>External Cephalic Version: ACOG Practice Bulletin, Number 221. Obstet Gynecol. 2020 May;135(5):e203-e212. doi: 10.1097/AOG.0000000000003837.</citation>
    <PMID>32332415</PMID>
  </reference>
  <results_reference>
    <citation>Seal SL, Dey A, Barman SC, Kamilya G, Mukherji J, Onwude JL. Randomized controlled trial of elevation of the fetal head with a fetal pillow during cesarean delivery at full cervical dilatation. Int J Gynaecol Obstet. 2016 May;133(2):178-82. doi: 10.1016/j.ijgo.2015.09.019. Epub 2016 Jan 15.</citation>
    <PMID>26868074</PMID>
  </results_reference>
  <results_reference>
    <citation>Hofmeyr GJ, Kulier R, West HM. External cephalic version for breech presentation at term. Cochrane Database Syst Rev. 2015 Apr 1;(4):CD000083. doi: 10.1002/14651858.CD000083.pub3. Review.</citation>
    <PMID>25828903</PMID>
  </results_reference>
  <results_reference>
    <citation>Kok M, Cnossen J, Gravendeel L, van der Post J, Opmeer B, Mol BW. Clinical factors to predict the outcome of external cephalic version: a metaanalysis. Am J Obstet Gynecol. 2008 Dec;199(6):630.e1-7; discussion e1-5. doi: 10.1016/j.ajog.2008.03.008. Epub 2008 May 23. Review.</citation>
    <PMID>18456227</PMID>
  </results_reference>
  <results_reference>
    <citation>Weiniger CF, Ginosar Y, Elchalal U, Sharon E, Nokrian M, Ezra Y. External cephalic version for breech presentation with or without spinal analgesia in nulliparous women at term: a randomized controlled trial. Obstet Gynecol. 2007 Dec;110(6):1343-50.</citation>
    <PMID>18055730</PMID>
  </results_reference>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>August 17, 2020</study_first_submitted>
  <study_first_submitted_qc>August 28, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 4, 2020</study_first_posted>
  <last_update_submitted>January 12, 2021</last_update_submitted>
  <last_update_submitted_qc>January 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Breech</keyword>
  <keyword>Version</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breech Presentation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>IPD will not be shared outside of research team.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

